Roche · 10 hours ago
2026 Summer Intern - Assay Transfer
Roche is a global healthcare company dedicated to advancing science and ensuring access to healthcare. The 2026 Summer Intern - Assay Transfer will support the transition of diagnostic assays from R&D to production and assist in maintaining metrics for Key Performance Indicators (KPIs).
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Learn and catalog the history of Assay Transfer using artificial intelligence tools
Support the pilot reagent manufacturing process
Maintain metrics for Key Performance Indicators (KPIs)
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Must have attained a Bachelor's Degree (not currently enrolled in a graduate program)
Must be pursuing a Master's Degree (enrolled student)
Basic experience with spreadsheet software such as Google Sheets or Excel. This includes the ability to sort and maintain data sets and basic use of formulas
Creation of presentations using Google Slides or Powerpoint
Knowledge of Windows platform
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Use of artificial intelligence (AI) to analyze data
Data analysis and trending
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase